Tagrisso HCP Website May 14, 2018May 16, 2018 Brand: Tagrisso (osimertinib), Tablets Parent Company: AstraZeneca Drug Type: Prescription Drug Category: Oncology Campaign: Post-Launch Targeting: HCPs Patient Website: https://www.tagrisso.com/ HCP Website: https://www.tagrissohcp.com/ Homepage Efficacy Dosing MOA Homepage (Mobile) Mobile Nav